Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Head and Neck Cancer

  Free Subscription

Articles published in Anticancer Res

Retrieve available abstracts of 421 articles:
HTML format

Single Articles

    September 2021
  1. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
    Fibrin/fibrinogen Degradation Products Are Associated With Tumor Stage and Prognosis in Patients Undergoing Resection of Esophageal Cancer.
    Anticancer Res. 2021;41:4523-4527.
    PubMed     Abstract available

  2. KAWASAKI M, Sakabe T, Kodani I, Umekita Y, et al
    Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4563-4570.
    PubMed     Abstract available

  3. KOIKE K, Nishiyama K, Dehari H, Ogi K, et al
    Prognostic Value of CD45Ro(+) T-Cell Expression in Patients With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4515-4522.
    PubMed     Abstract available

    August 2021
  4. AGAWA K, Yamashita K, Nakagawa A, Yamada K, et al
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4117-4126.
    PubMed     Abstract available

  5. TOKASHIKI K, Okamoto I, Okada T, Sato H, et al
    Postoperative Complications of Jejunal and Skin Valve Reconstruction in Free Reconstructive Surgery for Hypopharyngeal Carcinoma.
    Anticancer Res. 2021;41:4033-4038.
    PubMed     Abstract available

  6. LANDSTROM F, Kristiansson S, Reizenstein J
    The Role of Electrochemotherapy in Curative Treatment of Head and Neck Cancer and Advanced Skin Cancer: A Need for New Treatment Protocols?
    Anticancer Res. 2021;41:3977-3982.
    PubMed     Abstract available

  7. YAMASHITA K, Miyazaki Y, Nakatani D, Masuike Y, et al
    OSK-0028 in Patients With Esophageal Cancer Undergoing Esophagectomy: A Double-blind, Randomised Controlled Trial.
    Anticancer Res. 2021;41:3875-3884.
    PubMed     Abstract available

  8. DE OLIVEIRA NETO CP, Brito HO, DA Costa RMG, Brito LMO, et al
    Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis.
    Anticancer Res. 2021;41:3707-3716.
    PubMed     Abstract available

  9. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
    Combining Preoperative Immunoinflammatory Scores and (18)F-Fluorodeoxyglucose Positron-emission Tomography Predicts Beneficiaries of Salvage Esophagectomy.
    Anticancer Res. 2021;41:4005-4011.
    PubMed     Abstract available

  10. WU TK, Ou YC, Chen YP, Huang FM, et al
    Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
    Anticancer Res. 2021;41:3789-3799.
    PubMed     Abstract available

    July 2021
  11. CAO C, Poti SM, Ledgerwood LG, Lai J, et al
    Mixed HPV-related Neuroendocrine Carcinoma and HPV-related Squamous Cell Carcinoma of the Base of Tongue in a Patient With Incidental Identification of Synchronous Metastatic Papillary Thyroid Carcinoma.
    Anticancer Res. 2021;41:3639-3642.
    PubMed     Abstract available

  12. LANDSTROM F, Kristiansson S, Appelros P
    Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area.
    Anticancer Res. 2021;41:3519-3522.
    PubMed     Abstract available

  13. KNITTER S, Andreou A, Hofmann T, Chopra S, et al
    Minimally Invasive Versus Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching Analysis.
    Anticancer Res. 2021;41:3499-3510.
    PubMed     Abstract available

  14. LUNDIN E, Reizenstein J, Landstrom F, Bergqvist M, et al
    Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell Cancer.
    Anticancer Res. 2021;41:3489-3498.
    PubMed     Abstract available

  15. FUJITA J, Nakajima M, Muroi H, Kikuchi M, et al
    The Prognostic Significance of Plakophilin-1 Expression in Esophageal Cancer.
    Anticancer Res. 2021;41:3401-3407.
    PubMed     Abstract available

  16. KII T, Sakuma K, Tanaka A
    PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:3363-3370.
    PubMed     Abstract available

  17. HYAKUSOKU H, Sawakuma K, Sano D, Takahashi H, et al
    FosL1 Regulates Regional Metastasis of Head and Neck Squamous Cell Carcinoma by Promoting Cell Migration, Invasion, and Proliferation.
    Anticancer Res. 2021;41:3317-3326.
    PubMed     Abstract available

    June 2021
  18. STAACKMANN C, Ribbat-Idel J, Perner S, Idel C, et al
    Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival.
    Anticancer Res. 2021;41:3205-3210.
    PubMed     Abstract available

  19. HAMAI Y, Emi M, Ibuki Y, Kurokawa T, et al
    Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy.
    Anticancer Res. 2021;41:3011-3021.
    PubMed     Abstract available

  20. KYRODIMOS E, Chrysovergis A, Mastronikolis N, Tsiambas E, et al
    Impact of Topoisomerases Complex Deregulation on Head and Neck Carcinoma Genomic Instability.
    Anticancer Res. 2021;41:2773-2779.
    PubMed     Abstract available

  21. RADES D, Staackmann C, Ribbat-Idel J, Perner S, et al
    A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck.
    Anticancer Res. 2021;41:3055-3058.
    PubMed     Abstract available

  22. SARMA D, Karna R, Nasrullah A, Zhang Q, et al
    Primary Esophageal Small Cell Carcinoma Masquerading as Non-Hodgkin Lymphoma in a Young Patient.
    Anticancer Res. 2021;41:3023-3027.
    PubMed     Abstract available

  23. OKUHATA K, Monzen H, Tamura M, Matsumoto K, et al
    Plan Complexity and Delivery Accuracy of Knowledge-based Volumetric Modulated Arc Therapy Plans with Single Optimization for Oropharyngeal Cancer.
    Anticancer Res. 2021;41:2925-2931.
    PubMed     Abstract available

    May 2021
  24. RADES D, Staackmann C, Schild SE
    Karnofsky Performance Score - An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer.
    Anticancer Res. 2021;41:2495-2499.
    PubMed     Abstract available

  25. HAAG A, Huffman D, Peterson C, Shankar K, et al
    Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma.
    Anticancer Res. 2021;41:2485-2488.
    PubMed     Abstract available

  26. IWASAKI T, Onda T, Honda H, Hayashi K, et al
    Over-expression of PDE5 in Oral Squamous Cell Carcinoma - Effect of Sildenafil Citrate.
    Anticancer Res. 2021;41:2297-2306.
    PubMed     Abstract available

    April 2021
  27. YU WN, Lin HF, Lee YI, Shia WC, et al
    PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
    Anticancer Res. 2021;41:2177-2182.
    PubMed     Abstract available

  28. SAKAI M, Sohda M, Saito H, Nakazawa N, et al
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting.
    Anticancer Res. 2021;41:2141-2145.
    PubMed     Abstract available

  29. FRIEDRICH RE, Scheuer HT, Zustin J, Luebke AM, et al
    Microdont Developing Outside the Alveolar Process and Within Oral Diffuse and Plexiform Neurofibroma in Neurofibromatosis Type 1.
    Anticancer Res. 2021;41:2083-2092.
    PubMed     Abstract available

  30. SUZUKI M, Takenaka Y, Kishikawa T, Yamamoto Y, et al
    Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer.
    Anticancer Res. 2021;41:2045-2051.
    PubMed     Abstract available

  31. TAKAKUSAGI Y, Kusunoki T, Kano K, Anno W, et al
    Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer.
    Anticancer Res. 2021;41:1951-1958.
    PubMed     Abstract available

  32. FUKUDA M, Ogasawara Y, Hayashi H, Okuyama A, et al
    Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling.
    Anticancer Res. 2021;41:1785-1792.
    PubMed     Abstract available

  33. PAWLICZAK J, Kolb M, Bauer M, Gminski R, et al
    Micronucleus Formation in Primary Oropharyngeal Epithelial Cells Reveals Mutagenicity of Cement Dusts.
    Anticancer Res. 2021;41:1849-1858.
    PubMed     Abstract available

  34. HOTTA H, Hamamura K, Shibuya H, Ohmi Y, et al
    Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling.
    Anticancer Res. 2021;41:1821-1830.
    PubMed     Abstract available

  35. OGO A, Miyake S, Kubota H, Higashida M, et al
    The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
    Anticancer Res. 2021;41:1771-1778.
    PubMed     Abstract available

  36. KOERDT S, Raguse JD, Neumann F, Beck-Broichsitter B, et al
    Value of Panendoscopy in the Identification of Synchronous Malignancies in Patients Suffering from Oral Squamous Cell Carcinoma Without Clinical Signs of a Second Primary Tumor.
    Anticancer Res. 2021;41:2039-2044.
    PubMed     Abstract available

    March 2021
  37. MARCHAND-CRETY C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, et al
    Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
    Anticancer Res. 2021;41:1555-1561.
    PubMed     Abstract available

  38. FUKUDA N, Toda K, Ohmoto A, Wang X, et al
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Anticancer Res. 2021;41:1683-1691.
    PubMed     Abstract available

  39. OWIN N, Elsayad K, Rolf D, Haverkamp U, et al
    Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies.
    Anticancer Res. 2021;41:1587-1592.
    PubMed     Abstract available

  40. KURIYAMA K, Sohda M, Watanabe T, Saito H, et al
    Resistance to Preoperative Oral Care Is Associated With Postoperative Pneumonia After Oesophageal Cancer Surgery.
    Anticancer Res. 2021;41:1507-1514.
    PubMed     Abstract available

  41. FRANZEN AM, Windfuhr JP
    Tonsillectomy as a Prevention Strategy in the Light of Increasing Incidence of Oropharyngeal Cancer - a Research of Current Literature.
    Anticancer Res. 2021;41:1157-1161.
    PubMed     Abstract available

    February 2021
  42. MENG X, Matsumoto F, Mori T, Miura N, et al
    BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:1089-1099.
    PubMed     Abstract available

  43. MEIROVITZ A, Gross M, Leibovici V, Sheva K, et al
    Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients.
    Anticancer Res. 2021;41:1083-1087.
    PubMed     Abstract available

  44. NISHII N, Hirotsu Y, Koida N, Takahashi Y, et al
    Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
    Anticancer Res. 2021;41:1035-1040.
    PubMed     Abstract available

  45. TADA H, Takahashi H, Ida S, Mito I, et al
    The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:885-893.
    PubMed     Abstract available

  46. RADES D, Narvaez CA, Janssen S, SchrOder U, et al
    Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer.
    Anticancer Res. 2021;41:877-884.
    PubMed     Abstract available

  47. LEE HP, Tsai KW, Lee CC
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
    Anticancer Res. 2021;41:803-810.
    PubMed     Abstract available

  48. INOUE M, Takeuchi H, Matsuda S, Nishi T, et al
    IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
    Anticancer Res. 2021;41:783-794.
    PubMed     Abstract available

  49. UEDA S, Goto M, Hashimoto K, Imazawa M, et al
    Salivary CPLANE1 Levels as a Biomarker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:765-772.
    PubMed     Abstract available

  50. JIANG C, Lee SH, Park JH, Lee JS, et al
    A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
    Anticancer Res. 2021;41:687-697.
    PubMed     Abstract available

    January 2021
  51. NARVAEZ CA, Schild SE, Janssen S, Schroeder U, et al
    Accelerated Fractionation With Concomitant Boost vs. Conventional Radio-chemotherapy for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head-and-Neck (SCCHN).
    Anticancer Res. 2021;41:477-484.
    PubMed     Abstract available

  52. SOHDA M, Miyazaki T, Watanabe T, Nakazawa N, et al
    Utility of Thermography of Reconstructed Gastric Conduit for Predicting Postoperative Anastomotic Leakage After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2021;41:453-458.
    PubMed     Abstract available

  53. SASAKI K, Osako Y, Urata M, Noda M, et al
    Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy.
    Anticancer Res. 2021;41:385-389.
    PubMed     Abstract available

  54. ZHANG H, Yi J, Kim E, Choo Y, et al
    20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway.
    Anticancer Res. 2021;41:227-235.
    PubMed     Abstract available

  55. WILHELM C, Hackenberg S, Bregenzer M, Meyer T, et al
    Effect of Hypoxia on Proliferation and the Expression of the Genes HIF-1alpha and JMJD1A in Head and Neck Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2021;41:113-122.
    PubMed     Abstract available

  56. KOUKOURAKIS IM, Zygogianni A, Kouloulias V, Kyrgias G, et al
    Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?
    Anticancer Res. 2021;41:467-475.
    PubMed     Abstract available

  57. STARK CR, Gustavsson I, Horal P, Kotopouli M, et al
    Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis.
    Anticancer Res. 2021;41:269-277.
    PubMed     Abstract available

  58. LAI KC, Chia YT, Yih LH, Lu YL, et al
    Antitumor Effects of the Novel Quinazolinone Holu-12: Induction of Mitotic Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma CAL27 Cells.
    Anticancer Res. 2021;41:259-268.
    PubMed     Abstract available

  59. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Spyropoulou D, et al
    Comparative E-Cadherin Digital Expression Analysis in HPV and non-HPV Related Squamous Cell Carcinoma of the Oral Cavity.
    Anticancer Res. 2021;41:163-167.
    PubMed     Abstract available

  60. FURUKAWA K, Kawasaki G, Yoshida T, Umeda M, et al
    Clinicopathological and Prognostic Analysis of PD-L1 and PD-L2 Expression in Surgically Resected Primary Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:101-111.
    PubMed     Abstract available

  61. UCHI R, Jiromaru R, Yasumatsu R, Yamamoto H, et al
    Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma.
    Anticancer Res. 2021;41:71-79.
    PubMed     Abstract available

    December 2020
  62. SUGIURA K, Nakajima S, Kato I, Okubo-Sato M, et al
    Hypoxia and CD11b+ Cell Influx Are Strongly Associated With Lymph Node Metastasis of Oral Cancer.
    Anticancer Res. 2020;40:6845-6852.
    PubMed     Abstract available

  63. LIU B, Shiraga S, Mortenson MM, Lai J, et al
    Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:7053-7056.
    PubMed     Abstract available

  64. NECKEL N, Michael M, Troeltzsch D, WUster J, et al
    Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6987-6995.
    PubMed     Abstract available

  65. CHEN CH, Huang YC, Lee YH, Tan ZL, et al
    Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
    Anticancer Res. 2020;40:6723-6732.
    PubMed     Abstract available

    November 2020
  66. KIM SH, Cho YK, Huh JH, Kang JG, et al
    Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.
    Anticancer Res. 2020;40:6137-6150.
    PubMed     Abstract available

  67. TRUMBULL D, Lemini R, Attwood K, Kukar M, et al
    Gastric Cancer Disparities Among Asian American Subpopulations.
    Anticancer Res. 2020;40:6381-6385.
    PubMed     Abstract available

  68. DE JESUS OLIVEIRA KATO V, DE Abreu MC, DE Brito Kato AM, DE Souza LL, et al
    Significance of P16(INK4A) Expression and PTEN Loss of Heterozygosity in Human Papilloma Virus-related Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6355-6366.
    PubMed     Abstract available

  69. SUNG ES, Kim JY, Ahn YT, Lee IW, et al
    Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
    Anticancer Res. 2020;40:6295-6303.
    PubMed     Abstract available

  70. BIRK R, Schell A, Aderhold C, Hoch S, et al
    Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC.
    Anticancer Res. 2020;40:6195-6203.
    PubMed     Abstract available

  71. MARUYAMA N, Umikawa M, Matsumoto H, Maruyama T, et al
    miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).
    Anticancer Res. 2020;40:6101-6113.
    PubMed     Abstract available

  72. PELTONEN J, Tuomainen K, Sallinen T, Faress I, et al
    Effect of Sex Steroid Hormones on Tongue Cancer Cells In Vitro.
    Anticancer Res. 2020;40:6029-6037.
    PubMed     Abstract available

    October 2020
  73. KAWAKITA Y, Motoyama S, Sato Y, Wakita A, et al
    Prognostic Significance of Combined Platelet Distribution Width and C-Reactive Protein Score in Esophageal Cancer.
    Anticancer Res. 2020;40:5715-5725.
    PubMed     Abstract available

  74. SHIH LC, Tsai CW, Chang WS, Shen TC, et al
    Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan.
    Anticancer Res. 2020;40:5503-5508.
    PubMed     Abstract available

  75. KOENIGSBERG C, Ondrey FG
    Genomic Database Analysis for Head and Neck Cancer Prevention Targets: MTOR Signal Transduction Pathway.
    Anticancer Res. 2020;40:5417-5421.
    PubMed     Abstract available

  76. TAKAGI K, Buettner S, Ijzermans JNM, Wijnhoven BPL, et al
    Systematic Review on the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2020;40:5343-5349.
    PubMed     Abstract available

  77. HAAG A, Jayakrishnan T, Shah D, Sandhu A, et al
    First Reported Case of Localized Extra-pulmonary Small Cell Carcinoma (EPSC) of the Esophagus Treated With Triple Therapy.
    Anticancer Res. 2020;40:5919-5923.
    PubMed     Abstract available

  78. TANISHIMA Y, Nishikawa K, Arakawa Y, Matsumoto A, et al
    Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer.
    Anticancer Res. 2020;40:5829-5835.
    PubMed     Abstract available

  79. KUVENDJISKA J, Pitman MB, Martini V, Braun C, et al
    Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Anticancer Res. 2020;40:5679-5685.
    PubMed     Abstract available

  80. HUBER L, Birk R, Knuettel M, Rotter N, et al
    FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.
    Anticancer Res. 2020;40:5621-5630.
    PubMed     Abstract available

    September 2020
  81. FUSHIMI C, Okamoto I, Matsuki T, Masubuchi T, et al
    Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma.
    Anticancer Res. 2020;40:5277-5283.
    PubMed     Abstract available

  82. KUBOTA H, Hirai T, Yamauchi A, Ogo A, et al
    Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
    Anticancer Res. 2020;40:5043-5048.
    PubMed     Abstract available

  83. TERATANI M, Nakamura S, Sakagami H, Fujise M, et al
    Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.
    Anticancer Res. 2020;40:4885-4894.
    PubMed     Abstract available

    August 2020
  84. KUROKAWA T, Hamai Y, Emi M, Ibuki Y, et al
    Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy.
    Anticancer Res. 2020;40:4387-4394.
    PubMed     Abstract available

  85. LEE MY, Fowler N, Adelstein D, Koyfman S, et al
    Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin.
    Anticancer Res. 2020;40:4207-4214.
    PubMed     Abstract available

  86. TSUCHIHASHI K, Nakatsugawa M, Kobayashi JI, Sasaya T, et al
    Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4319-4326.
    PubMed     Abstract available

    July 2020
  87. KUBO K, Murakami Y, Imano N, Takeuchi Y, et al
    A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers.
    Anticancer Res. 2020;40:4183-4190.
    PubMed     Abstract available

  88. JEONG JY, Park TI, Ahn D
    Comprehensive Analysis and Clinical Implication of PD-L1 Expression Considering HPV Status in Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4001-4010.
    PubMed     Abstract available

  89. KOMATSU N, Komatsu M, Ohashi R, Horii A, et al
    Photosensitizer With Illumination Enhances In Vivo Antitumor Effect of Anti-ROBO1 Immunotoxin on Maxillary Sinus Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3793-3799.
    PubMed     Abstract available

  90. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Tsiambas E, et al
    Chromosome 17 In Situ Hybridization Grid-based Analysis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3759-3764.
    PubMed     Abstract available

  91. LI CH, Shih LC, Hsu CL, Lee HT, et al
    The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.
    Anticancer Res. 2020;40:3707-3712.
    PubMed     Abstract available

  92. IIJIMA Y, Bandow K, Amano S, Sano M, et al
    Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
    Anticancer Res. 2020;40:3685-3696.
    PubMed     Abstract available

  93. KRAMER B, Schell A, Aderhold C, Huber L, et al
    Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3847-3855.
    PubMed     Abstract available

  94. CHO JM, Lee HJ, Chung JH, Kim WY, et al
    Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Anticancer Res. 2020;40:3801-3809.
    PubMed     Abstract available

    June 2020
  95. TADA H, Takahashi H, Ida S, Nagata Y, et al
    Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3559-3564.
    PubMed     Abstract available

  96. HIRAKAWA H, Ikegami T, Azechi S, Agena S, et al
    Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms.
    Anticancer Res. 2020;40:3277-3285.
    PubMed     Abstract available

  97. ROSAS R, Buryska S, Silver R, Wuertz B, et al
    Retinoids Augment Thiazolidinedione PPARgamma Activation in Oral Cancer Cells.
    Anticancer Res. 2020;40:3071-3080.
    PubMed     Abstract available

  98. SAMHOURI L, Kriz J, Elsayad K, Channaoui M, et al
    The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
    Anticancer Res. 2020;40:3379-3386.
    PubMed     Abstract available

  99. TUNG KL, Wu YT, Liu C, Lin SC, et al
    EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro.
    Anticancer Res. 2020;40:3255-3264.
    PubMed     Abstract available

    May 2020
  100. KIDOGAMI S, Iguchi T, Sato K, Yoshikawa Y, et al
    SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2941-2946.
    PubMed     Abstract available

  101. TAKAHASHI K, Osaka Y, Ota Y, Watanabe T, et al
    Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer.
    Anticancer Res. 2020;40:2827-2832.
    PubMed     Abstract available

  102. UTISPAN K, Koontongkaew S
    High Nitric Oxide Adaptation in Isogenic Primary and Metastatic Head and Neck Cancer Cells.
    Anticancer Res. 2020;40:2657-2665.
    PubMed     Abstract available

  103. KANGBOONRUANG K, Wongtrakoongate P, Lertsuwan K, Khachonkham S, et al
    MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin.
    Anticancer Res. 2020;40:2645-2655.
    PubMed     Abstract available

  104. PARK JJ, Hah YS, Ryu S, Cheon SY, et al
    Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Via Epithelial-to-Mesenchymal Transition.
    Anticancer Res. 2020;40:2627-2635.
    PubMed     Abstract available

  105. AHN SH, Song S, Kim S
    Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model.
    Anticancer Res. 2020;40:2707-2713.
    PubMed     Abstract available

  106. OAK ASW, Bocheva G, Kim TK, Brozyna AA, et al
    Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/beta-Catenin Pathways.
    Anticancer Res. 2020;40:2467-2474.
    PubMed     Abstract available

    April 2020
  107. KOMORI MF, Kimura T, Kariya S, Onoda T, et al
    Epidemiological Correlations Between Head and Neck Cancer and Hepatitis B Core Antibody Positivity.
    Anticancer Res. 2020;40:2393-2403.
    PubMed     Abstract available

  108. LIN CY, Fang HY, Lein MY, Lin CC, et al
    Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
    Anticancer Res. 2020;40:2387-2392.
    PubMed     Abstract available

  109. TAMAGAWA H, Aoyama T, Tamagawa A, Komori K, et al
    Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Anticancer Res. 2020;40:2365-2371.
    PubMed     Abstract available

  110. AOYAMA T, Atsumi Y, Hara K, Kazama K, et al
    Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment.
    Anticancer Res. 2020;40:2359-2364.
    PubMed     Abstract available

  111. EGGERSMANN TK, Baumeister P, Kumbrink J, Mayr D, et al
    Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Anticancer Res. 2020;40:2117-2123.
    PubMed     Abstract available

  112. TOYA R, Saito T, Matsuyama T, Kai Y, et al
    Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2073-2077.
    PubMed     Abstract available

  113. YAMAMOTO T, Niibe Y, Matsumoto Y, Dekura Y, et al
    Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.
    Anticancer Res. 2020;40:2065-2072.
    PubMed     Abstract available

  114. TAKAHASHI M, Fukuda K, Saikawa Y, Nakamura R, et al
    Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:1921-1930.
    PubMed     Abstract available

  115. INSODAITE R, Liutkevicius V, Uloza V, Solovejute R, et al
    Association Between MMP8 Gene Polymorphisms and Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2003-2009.
    PubMed     Abstract available

  116. SHIMODA Y, Yamada T, Komori K, Watanabe H, et al
    Effect of Muscle Mass Loss After Esophagectomy on Prognosis of Oesophageal Cancer.
    Anticancer Res. 2020;40:2275-2281.
    PubMed     Abstract available

    March 2020
  117. KOH HK, Park Y, Koo T, Park HJ, et al
    Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:1771-1778.
    PubMed     Abstract available

  118. DAVAKIS S, Syllaios A, Sdralis E, Lorenzi B, et al
    Hybrid Minimally-invasive Esophagectomy for Esophageal Cancer: Clinical and Oncological Outcomes.
    Anticancer Res. 2020;40:1753-1758.
    PubMed     Abstract available

  119. NGUYEN T, Bartscht T, Schild SE, Rades D, et al
    A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation.
    Anticancer Res. 2020;40:1661-1664.
    PubMed     Abstract available

  120. IGUCHI K, Kunisaki C, Sato S, Tanaka Y, et al
    Efficacy of Video-assisted Thoracoscopic Esophagectomy for Stage II/III Esophageal Cancer: Analysis Using the Propensity Scoring System.
    Anticancer Res. 2020;40:1587-1595.
    PubMed     Abstract available

  121. SIMON F, Schwenk-Zieger S, Becker S, Unger K, et al
    Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells - Role of ABCG2.
    Anticancer Res. 2020;40:1277-1284.
    PubMed     Abstract available

  122. KIM HJ, Lee HJ, Jung JH, Kim WW, et al
    Ultrasound Assessment of Synchronous Thyroid Nodules in Patients With Papillary Thyroid Cancer: A Nodule-by-nodule Analysis Between Ultrasound and Pathology.
    Anticancer Res. 2020;40:1779-1786.
    PubMed     Abstract available

  123. VITOLO V, Barcellini A, Mirandola A, Facoetti A, et al
    Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?
    Anticancer Res. 2020;40:1645-1649.
    PubMed     Abstract available

  124. SAITO M, Fujita Y, Kuribayashi N, Uchida D, et al
    Troglitazone, a Selective Ligand for PPARgamma, Induces Cell-cycle Arrest in Human Oral SCC Cells.
    Anticancer Res. 2020;40:1247-1254.
    PubMed     Abstract available

    February 2020
  125. HUANG CH, Lue KH, Hsieh TC, Liu SH, et al
    Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.
    Anticancer Res. 2020;40:1175-1181.
    PubMed     Abstract available

  126. SIERON HL, Eberle F, Gress TM, Mahnken AH, et al
    Safety of Prophylactic Gastrostomy Tube Placement and Gastrostomy Tube Usage in Patients Treated by Radio(chemo)therapy for Head and Neck Cancer.
    Anticancer Res. 2020;40:1167-1173.
    PubMed     Abstract available

  127. OHSAWA M, Hamai Y, Emi M, Takaoki F, et al
    Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery.
    Anticancer Res. 2020;40:1153-1160.
    PubMed     Abstract available

  128. SUZUKI H, Nishikawa D, Beppu S, Terada H, et al
    Prognostic Value of Age and Distant Metastasis in Differentiated Thyroid Carcinoma Undergoing Salvage Surgery.
    Anticancer Res. 2020;40:1127-1133.
    PubMed     Abstract available

  129. AOYAMA T, Hara K, Kazama K, Atsumi Y, et al
    The Short- and Long-term Outcomes of Esophagectomy for Esophageal Cancer in Patients Older than 75 Years.
    Anticancer Res. 2020;40:1087-1093.
    PubMed     Abstract available

  130. YOU JS, Lim H, Kim TH, Oh JS, et al
    25-Hydroxycholesterol Induces Death Receptor-mediated Extrinsic and Mitochondria-dependent Intrinsic Apoptosis in Head and Neck Squamous Cell Carcinoma Cells.
    Anticancer Res. 2020;40:779-788.
    PubMed     Abstract available

  131. WAER CN, Kaur P, Tumur Z, Hui DD, et al
    Rosmarinic Acid/ Blue Light Combination Treatment Inhibits Head and Neck Squamous Cell Carcinoma In Vitro.
    Anticancer Res. 2020;40:751-758.
    PubMed     Abstract available

  132. PSOMA E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, et al
    Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.
    Anticancer Res. 2020;40:677-688.
    PubMed     Abstract available

  133. SATOMI-TSUSHITA N, Honma Y, Nagashima K, Ito Y, et al
    Risk Factors of Severe Benign Cicatricial Stricture After Definitive Chemoradiation for Localized T3 Esophageal Carcinoma.
    Anticancer Res. 2020;40:1071-1077.
    PubMed     Abstract available

  134. BAUMGARTNER R, Taghizadeh H, Jomrich G, Schoppmann SF, et al
    Utilization and Efficacy of Palliative Chemotherapy for Locally Advanced or Metastatic Gastroesophageal Carcinoma.
    Anticancer Res. 2020;40:965-975.
    PubMed     Abstract available

  135. MIYAMOTO K, Minegaki T, Hirano S, Hayashi I, et al
    Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells.
    Anticancer Res. 2020;40:813-823.
    PubMed     Abstract available

  136. PAPANIKOLAOU V, Chrysovergis A, Mastronikolis N, Tsiambas E, et al
    Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:807-811.
    PubMed     Abstract available

    January 2020
  137. AOYAMA T, Kazama K, Atsumi Y, Tamagawa H, et al
    Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence.
    Anticancer Res. 2020;40:443-449.
    PubMed     Abstract available

  138. OLEJAR T, Vetvicka D, Boucek J, Zabrodsky M, et al
    The FSHR Expression in Head and Neck Squamous Cell Cancer. A Pilot Immunohistochemical Study.
    Anticancer Res. 2020;40:349-356.
    PubMed     Abstract available

  139. ROMEO V, Cuocolo R, Ricciardi C, Ugga L, et al
    Prediction of Tumor Grade and Nodal Status in Oropharyngeal and Oral Cavity Squamous-cell Carcinoma Using a Radiomic Approach.
    Anticancer Res. 2020;40:271-280.
    PubMed     Abstract available

  140. EUN YG, Yoon YJ, Won KY, Lee YC, et al
    Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model.
    Anticancer Res. 2020;40:191-199.
    PubMed     Abstract available

  141. LI J, Vangundy Z, Poi M
    Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines.
    Anticancer Res. 2020;40:67-73.
    PubMed     Abstract available

    December 2019
  142. GREHN M, Stille M, Ziemann C, Cremers F, et al
    A New Phantom for Individual Verification of the Dose Distribution in Precision Radiotherapy for Head-and-Neck Cancer.
    Anticancer Res. 2019;39:6931-6938.
    PubMed     Abstract available

  143. SANO D, Fujisawa T, Tokuhisa M, Shimizu M, et al
    Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.
    Anticancer Res. 2019;39:6819-6827.
    PubMed     Abstract available

  144. MORIMOTO M, Bijl HP, VAN DER Schaaf A, Xu CJ, et al
    Development of Normal Tissue Complication Probability Model for Trismus in Head and Neck Cancer Patients Treated With Radiotherapy: The Role of Dosimetric and Clinical Factors.
    Anticancer Res. 2019;39:6787-6798.
    PubMed     Abstract available

  145. LI CH, Sun KT, Li X, Shih LC, et al
    The Joint Effect of Interleukin-12B rs3212227 Genotype and Behavioral Factors on Oral Cancer Risk in Taiwanese.
    Anticancer Res. 2019;39:6515-6521.
    PubMed     Abstract available

  146. IIJIMA Y, Bandow K, Sano M, Hino S, et al
    In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs.
    Anticancer Res. 2019;39:6673-6684.
    PubMed     Abstract available

  147. UESAWA Y, Nagai J, Shi H, Sakagami H, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Styrylchromones.
    Anticancer Res. 2019;39:6489-6498.
    PubMed     Abstract available

  148. NAGAI J, Shi H, Sezaki N, Yoshida N, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
    Anticancer Res. 2019;39:6479-6488.
    PubMed     Abstract available

  149. NAKAMURA J, Furuya S, Hagio K, Maruyama S, et al
    Differential miRNA Expression in Basaloid Squamous Cell Carcinoma of the Oesophagus: miR-3687 Targets PGRMC2.
    Anticancer Res. 2019;39:6471-6478.
    PubMed     Abstract available

  150. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Abstract available

    November 2019
  151. HO ML, Kuo WK, Chu LJ, Yeh IH, et al
    N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
    Anticancer Res. 2019;39:6317-6324.
    PubMed     Abstract available

  152. CHO YA, Kim EK, Cho BC, Koh YW, et al
    Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node Metastasis.
    Anticancer Res. 2019;39:6307-6316.
    PubMed     Abstract available

  153. JALY AA, Thway K, Touska P, Wale A, et al
    Imaging Soft-tissue Sarcomas of the Head and Neck: A Tertiary Soft-tissue Sarcoma Unit Experience.
    Anticancer Res. 2019;39:6223-6230.
    PubMed     Abstract available

  154. MORO Y, Kogashiwa Y, Sakurai H, Takahashi R, et al
    In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells.
    Anticancer Res. 2019;39:6041-6047.
    PubMed     Abstract available

  155. UNO Y, Kanda M, Sato Y, Shimizu D, et al
    Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:6015-6023.
    PubMed     Abstract available

  156. BABA H, Kanda M, Sawaki K, Shimizu D, et al
    PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:5943-5951.
    PubMed     Abstract available

  157. MURATA T, Shimizu K, Kurohara K, Tomeoku A, et al
    Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.
    Anticancer Res. 2019;39:6057-6062.
    PubMed     Abstract available

  158. EIN L, Mei C, Bracho O, Bas E, et al
    Modulation of BDNF-TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion In Vitro.
    Anticancer Res. 2019;39:5933-5942.
    PubMed     Abstract available

    October 2019
  159. GUO JC, Lin CC, Lin CY, Hsieh MS, et al
    Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Anticancer Res. 2019;39:5675-5682.
    PubMed     Abstract available

  160. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Diameter of External Carotid Arteries in Patients With Mandibular Osteoradionecrosis.
    Anticancer Res. 2019;39:5689-5693.
    PubMed     Abstract available

  161. SEKIMIZU M, Ozawa H, Saito S, Ikari Y, et al
    Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
    Anticancer Res. 2019;39:5623-5630.
    PubMed     Abstract available

    September 2019
  162. KALFERT D, Ludvik J, Kucera R, Topolcan O, et al
    Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2019;39:5171-5177.
    PubMed     Abstract available

  163. PARK SR, Yoon DH, Kim JH, Kim YH, et al
    A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO).
    Anticancer Res. 2019;39:5123-5133.
    PubMed     Abstract available

  164. LOGANADANE G, Kann BH, Park HS, Johnson SB, et al
    Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.
    Anticancer Res. 2019;39:4885-4890.
    PubMed     Abstract available

  165. FRANZEN A, Gunzel T, Buchali A, Coordes A, et al
    Cystic Lateral Neck Lesions: Etiologic and Differential Diagnostic Significance in a Series of 133 Patients.
    Anticancer Res. 2019;39:5047-5052.
    PubMed     Abstract available

  166. OGINO I, Watanabe S, Misumi T, Hata M, et al
    Lymph Node Metastases Diagnosed by (18)F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy.
    Anticancer Res. 2019;39:4977-4985.
    PubMed     Abstract available

    August 2019
  167. FUKUOKA E, Yamashita K, Tanaka T, Sawada R, et al
    Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8(+) Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4539-4548.
    PubMed     Abstract available

  168. TANAKA Y, Ueno T, Yoshida N, Akutsu Y, et al
    Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study.
    Anticancer Res. 2019;39:4441-4448.
    PubMed     Abstract available

  169. OHSAWA M, Hamai Y, Ibuki Y, Emi M, et al
    Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report.
    Anticancer Res. 2019;39:4399-4403.
    PubMed     Abstract available

  170. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2019;39:4337-4342.
    PubMed     Abstract available

  171. JINGU K, Takahashi N, Murakami Y, Ishikawa K, et al
    Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?
    Anticancer Res. 2019;39:4279-4283.
    PubMed     Abstract available

  172. MATSUMOTO A, Yuda M, Tanaka Y, Tanishima Y, et al
    Efficacy of Percutaneous Endoscopic Gastrostomy for Patients With Esophageal Cancer During Preoperative Therapy.
    Anticancer Res. 2019;39:4243-4248.
    PubMed     Abstract available

  173. MATSUNAGA N, Wakasaki T, Yasumatsu R, Kotake Y, et al
    Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4073-4077.
    PubMed     Abstract available

  174. SDRALIS EK, Davakis S, Syllaios A, Lorenzi B, et al
    Prognostic Value of Subcarinal Lymph Nodes in Minimally Invasive Esophagectomy for Cancer.
    Anticancer Res. 2019;39:4291-4295.
    PubMed     Abstract available

  175. TOMASOVIC-LONCARIC C, Fucic A, Andabak A, Andabak M, et al
    Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk.
    Anticancer Res. 2019;39:4285-4289.
    PubMed     Abstract available

  176. CHRYSOVERGIS A, Papanikolaou V, Tsiambas E, Stavraka C, et al
    P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
    Anticancer Res. 2019;39:4137-4142.
    PubMed     Abstract available

  177. HUANG TS, Lee JJ, Li YS, Cheng SP, et al
    Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.
    Anticancer Res. 2019;39:4095-4100.
    PubMed     Abstract available

    July 2019
  178. TOAN NL, Hang NT, Luu NK, VAN Mao C, et al
    Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer.
    Anticancer Res. 2019;39:3727-3737.
    PubMed     Abstract available

  179. LANDGRAF V, Griessmann M, Roller J, Polednik C, et al
    DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines.
    Anticancer Res. 2019;39:3633-3639.
    PubMed     Abstract available

  180. SEO YS, Kim TH, Lim H, Oh JS, et al
    Phenformin Induces Caspase-dependent Apoptosis of FaDu Head and Neck Squamous Cell Carcinoma Cells.
    Anticancer Res. 2019;39:3499-3506.
    PubMed     Abstract available

  181. ITO T, Honma Y, Hirano H, Shoji H, et al
    S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal Carcinoma.
    Anticancer Res. 2019;39:3931-3936.
    PubMed     Abstract available

  182. STAUB Y, Nishiyama A, Suga Y, Fujita M, et al
    Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.
    Anticancer Res. 2019;39:3871-3878.
    PubMed     Abstract available

  183. KIM JY, Park YJ, Lee BM, Yoon S, et al
    Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Anticancer Res. 2019;39:3757-3765.
    PubMed     Abstract available

  184. UCHIDA S, Kobayashi K, Ohno S, Sakagami H, et al
    Induction of Non-Apoptotic Cell Death by Adrenergic Agonists in Human Oral Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2019;39:3519-3529.
    PubMed     Abstract available

  185. IMANARI K, Hashimoto M, Wakabayashi H, Okudaira N, et al
    Quantitative Structure-Cytotoxicity Relationship of Azulene Amide Derivatives.
    Anticancer Res. 2019;39:3507-3518.
    PubMed     Abstract available

    June 2019
  186. KITAGAWA H, Iwabu J, Yokota K, Namikawa T, et al
    Intraoperative Neurological Monitoring During Neck Dissection for Esophageal Cancer With Aberrant Subclavian Artery.
    Anticancer Res. 2019;39:3203-3205.
    PubMed     Abstract available

  187. MIKOSHIBA T, Ozawa H, Saito S, Ikari Y, et al
    Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients.
    Anticancer Res. 2019;39:3059-3065.
    PubMed     Abstract available

  188. TOYOKAWA T, Tamura T, Sakurai K, Kubo N, et al
    Postoperative Inflammation Is an Independent Prognostic Factor in Patients With Thoracic Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2777-2784.
    PubMed     Abstract available

  189. LORENZI B, Davakis S, Syllaios A, Kordzadeh A, et al
    Minimally Invasive Circumferential Hiatal Dissection for the Treatment of Adenocarcinoma of the Distal Esophagus and Esophago-gastric Junction: Technical Considerations Combined With Histopathological Outcomes.
    Anticancer Res. 2019;39:3219-3225.
    PubMed     Abstract available

  190. ZHANG D, Liao X, Tang Y, Meyer RG, et al
    Warthin-like Mucoepidermoid Carcinoma of the Parotid Gland: Unusual Morphology and Diagnostic Pitfalls.
    Anticancer Res. 2019;39:3213-3217.
    PubMed     Abstract available

  191. GOTO M, Okitsu H, Yuasa Y, Kuramoto S, et al
    Thoracoscopic Oesophagectomy Using Prone Positioning for Oesophageal Cancer With Right Aortic Arch: A Case Report.
    Anticancer Res. 2019;39:3207-3211.
    PubMed     Abstract available

  192. SOHDA M, Miyazaki T, Sakai M, Kumakura Y, et al
    Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.
    Anticancer Res. 2019;39:3167-3175.
    PubMed     Abstract available

  193. TAKAHASHI H, Sakakura K, Arisaka Y, Tokue A, et al
    Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:3039-3046.
    PubMed     Abstract available

  194. HUANG SJ, Tseng YK, Lo YH, Wu PC, et al
    Association of SDF-1 and CXCR4 Polymorphisms With Susceptibility to Oral and Pharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2891-2902.
    PubMed     Abstract available

  195. KARAGIANNIS AK, Philippou A, Tseleni-Balafouta S, Zevolis E, et al
    IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
    Anticancer Res. 2019;39:2811-2819.
    PubMed     Abstract available

  196. LIU C, Jiang YH, Zhao ZL, Wu HW, et al
    Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2019;39:2729-2737.
    PubMed     Abstract available

  197. MIRONSKA A, Lukaszewicz-Zajac M, Mroczko B
    Clinical Significance of Selected Chemokines in Thyroid Cancer.
    Anticancer Res. 2019;39:2715-2720.
    PubMed     Abstract available

    May 2019
  198. TAMAGAWA A, Aoyama T, Tamagawa H, Ju M, et al
    Influence of Postoperative Pneumonia on Esophageal Cancer Survival and Recurrence.
    Anticancer Res. 2019;39:2671-2678.
    PubMed     Abstract available

  199. SAEJIA P, Lirdprapamongkol K, Svasti J, Paricharttanakul NM, et al
    Perfluorooctanoic Acid Enhances Invasion of Follicular Thyroid Carcinoma Cells Through NF-kappaB and Matrix Metalloproteinase-2 Activation.
    Anticancer Res. 2019;39:2429-2435.
    PubMed     Abstract available

  200. TANAKA Y, Yamada A, Hirata S, Tanaka H, et al
    Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study.
    Anticancer Res. 2019;39:2615-2625.
    PubMed     Abstract available

  201. JEHN P, Dittmann J, Zimmerer R, Stier R, et al
    Survival Rates According to Tumour Location in Patients With Surgically Treated Oral and Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2527-2533.
    PubMed     Abstract available

  202. MORIKAWA T, Kosugi A, Shibahara T
    The Utility of Optical Instrument "ORALOOK(R)" in the Early Detection of High-risk Oral Mucosal Lesions.
    Anticancer Res. 2019;39:2519-2525.
    PubMed     Abstract available

  203. GADDUCCI A, Giuliani D, Cosio S, Lissoni A, et al
    Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.
    Anticancer Res. 2019;39:2513-2517.
    PubMed     Abstract available

  204. ANTUNES DM, Rodrigues MFSD, Guimaraes DM, Duarte CME, et al
    Nonsteroidal Anti-inflammatory Drugs Modulate Gene Expression of Inflammatory Mediators in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2385-2394.
    PubMed     Abstract available

  205. NOWINSKA K, Ciesielska U, Piotrowska A, Jablonska K, et al
    MCM5 Expression Is Associated With the Grade of Malignancy and Ki-67 Antigen in LSCC.
    Anticancer Res. 2019;39:2325-2335.
    PubMed     Abstract available

    April 2019
  206. PAENG JY, Kim JW, Lee ST
    Changes in Hyoid Bone Position and Cross-sectional Area of Pharyngeal Airway After Oral Cancer Surgery.
    Anticancer Res. 2019;39:2097-2104.
    PubMed     Abstract available

  207. WOOKEY VB, Appiah AK, Kallam A, Ernani V, et al
    HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2019;39:1907-1914.
    PubMed     Abstract available

  208. HUANG CH, Hsieh TC, Chang BS, Wang TF, et al
    Enteral Access Potentially Endangers Esophageal Carcinoma Patients Under Multi-modality Therapy: A Population-based Study.
    Anticancer Res. 2019;39:2227-2232.
    PubMed     Abstract available

  209. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Abstract available

  210. DE PAZ D, Young CK, Chien HT, Tsao CK, et al
    Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2025-2033.
    PubMed     Abstract available

  211. DE SANCTIS V, Belgioia L, Cante D, LA Porta MR, et al
    Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.
    Anticancer Res. 2019;39:1935-1942.
    PubMed     Abstract available

  212. FUJIMASA K, Ohike N, Norose T, Isobe T, et al
    Frequent and Specific Involvement of Changes of the p16-RB Pathway in Esophageal Neuroendocrine Carcinoma.
    Anticancer Res. 2019;39:1927-1934.
    PubMed     Abstract available

  213. MIYAMOTO K, Minegaki T, Tanahashi M, Yamamoto A, et al
    Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2019;39:1813-1820.
    PubMed     Abstract available

  214. AURELLO P, Berardi G, Moschetta G, Cinquepalmi M, et al
    Recurrence Following Anastomotic Leakage After Surgery for Carcinoma of the Distal Esophagus and Gastroesophageal Junction: A Systematic Review.
    Anticancer Res. 2019;39:1651-1660.
    PubMed     Abstract available

    March 2019
  215. HAMAI Y, Emi M, Ibuki Y, Murakami Y, et al
    Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1433-1440.
    PubMed     Abstract available

  216. NOZATO T, Koizumi T, Hayashi Y, Iida M, et al
    Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.
    Anticancer Res. 2019;39:1365-1373.
    PubMed     Abstract available

  217. NAKAMURA H, Tamaki S, Yagyuu T, Yamakawa N, et al
    Relationship Between EGFR Expression in Oral Cancer Cell Lines and Cetuximab Antibody-dependent Cell-mediated Cytotoxicity.
    Anticancer Res. 2019;39:1275-1282.
    PubMed     Abstract available

  218. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Abstract available

  219. MOTOYAMA S, Sato Y, Wakita A, Kawakita Y, et al
    Extensive Lymph Node Dissection Around the Left Laryngeal Nerve Achieved With Robot-assisted Thoracoscopic Esophagectomy.
    Anticancer Res. 2019;39:1337-1342.
    PubMed     Abstract available

  220. SUNDBERG J, Korytowska M, Burgos PM, Blomgren J, et al
    Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1293-1300.
    PubMed     Abstract available

  221. CHRYSOVERGIS A, Papanikolaou VS, Tsiambas E, Ragos V, et al
    Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1253-1257.
    PubMed     Abstract available

  222. MURAKI Y, Hasegawa T, Takeda D, Ueha T, et al
    Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1205-1216.
    PubMed     Abstract available

  223. KEMPER M, Strohm T, Grupp K, Ghadban T, et al
    Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.
    Anticancer Res. 2019;39:1191-1196.
    PubMed     Abstract available

    February 2019
  224. TAI TS, Lin PM, Wu CF, Hung SK, et al
    CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An In Vitro Study.
    Anticancer Res. 2019;39:713-720.
    PubMed     Abstract available

  225. SUZUKI H, Tamaki T, Nishio M, Terada H, et al
    Uptake of (18)F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage.
    Anticancer Res. 2019;39:1043-1049.
    PubMed     Abstract available

  226. ASAKA S, Shimakawa T, Yamaguchi K, Katsube T, et al
    Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome.
    Anticancer Res. 2019;39:979-985.
    PubMed     Abstract available

  227. LI MU, Gu S, Mao R, Ning Y, et al
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
    Anticancer Res. 2019;39:949-956.
    PubMed     Abstract available

  228. ELTWERI AM, Thomas AL, Chung WY, Morgan B, et al
    The Effect of Supplementary Omegaven(R) on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
    Anticancer Res. 2019;39:853-861.
    PubMed     Abstract available

  229. ISRAEL Y, Rachmiel A, Gourevich K, Nagler R, et al
    Survival Probabilities Related to Histology, Grade and Stage in Patients With Salivary Gland Tumors.
    Anticancer Res. 2019;39:641-647.
    PubMed     Abstract available

  230. HAGIO K, Furuya S, Nakamura J, Maruyama S, et al
    High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma.
    Anticancer Res. 2019;39:557-565.
    PubMed     Abstract available

    January 2019
  231. NISHIUMI S, Fujigaki S, Kobayashi T, Kojima T, et al
    Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:519-526.
    PubMed     Abstract available

  232. LI CC, Fang HY, Lin CY, Shen WC, et al
    Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
    Anticancer Res. 2019;39:511-517.
    PubMed     Abstract available

  233. NOMOTO D, Yoshida N, Akiyama T, Kiyozumi Y, et al
    Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2019;39:471-475.
    PubMed     Abstract available

  234. KITAGAWA H, Namikawa T, Iwabu J, Uemura S, et al
    Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2019;39:467-470.
    PubMed     Abstract available

  235. MATSUNAGA T, Miyata H, Sugimura K, Motoori M, et al
    Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.
    Anticancer Res. 2019;39:449-458.
    PubMed     Abstract available

  236. ZEMBSKA A, Jawiarczyk-Przybylowska A, Wojtczak B, Bolanowski M, et al
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Anticancer Res. 2019;39:33-40.
    PubMed     Abstract available

  237. FURUKAWA K, Kawasaki G, Naruse T, Umeda M, et al
    Prognostic Significance of Pretreatment Lymphocyte-to-Monocyte Ratio in Patients with Tongue Cancer.
    Anticancer Res. 2019;39:405-412.
    PubMed     Abstract available

  238. LUNDIN E, Bergqvist M, Ahlgren J, Reizenstein J, et al
    Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in Orebro.
    Anticancer Res. 2019;39:285-289.
    PubMed     Abstract available

  239. DE MOURA CFG, Soares GR, Ribeiro FAP, Silva MJD, et al
    Evaluation of the Chemopreventive Activity of Grape Skin Extract Using Medium-term Oral Carcinogenesis Assay Induced by 4-Nitroquinoline 1-Oxide.
    Anticancer Res. 2019;39:177-182.
    PubMed     Abstract available

    December 2018
  240. HUANG CH, Wang TF, Wu YF, Cheng YT, et al
    Efficacy of Enteral Access in Patients with Esophageal Squamous Cell Carcinoma Under Neoadjuvant Therapy.
    Anticancer Res. 2018;38:6939-6945.
    PubMed     Abstract available

  241. TSAI CW, Hsu HM, Wang YC, Chang WS, et al
    Contribution of MMP2 Promoter Genotypes to Oral Cancer Susceptibility, Recurrence and Metastasis in Taiwan.
    Anticancer Res. 2018;38:6821-6826.
    PubMed     Abstract available

  242. NAKASHIMA Y, Saeki H, Hu Q, Tsuda Y, et al
    Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6809-6814.
    PubMed     Abstract available

  243. HAMADA J, Konishi H, Shiozaki A, Fujiwara H, et al
    Management of Pleural Effusion After Mediastinoscopic Radical Esophagectomy.
    Anticancer Res. 2018;38:6919-6925.
    PubMed     Abstract available

  244. FUSHIMI A, Takeyama H, Manome Y
    Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines.
    Anticancer Res. 2018;38:6759-6762.
    PubMed     Abstract available

  245. MURATA T, Kutsuna T, Kurohara K, Shimizu K, et al
    Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2018;38:6715-6720.
    PubMed     Abstract available

  246. MASSIMINO M, Tirro E, Stella S, Frasca F, et al
    Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.
    Anticancer Res. 2018;38:6653-6662.
    PubMed     Abstract available

    November 2018
  247. KATSURAHARA K, Shiozaki A, Fujiwara H, Konishi H, et al
    Relationship Between Postoperative CRP and Prognosis in Thoracic Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6513-6518.
    PubMed     Abstract available

  248. ISOZAKI Y, Yasuda S, Akutsu Y, Shimada H, et al
    Salvage Carbon-ion Radiotherapy for Isolated Lymph Node Recurrence Following Curative Resection of Esophageal Cancer.
    Anticancer Res. 2018;38:6453-6458.
    PubMed     Abstract available

  249. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Anticancer Res. 2018;38:6339-6352.
    PubMed     Abstract available

  250. BABA J, Kioi M, Akimoto K, Nagashima Y, et al
    Atypical Protein Kinase C lambda/iota Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6291-6297.
    PubMed     Abstract available

  251. SUZUKI H, Takano G, Hanai N, Nishikawa D, et al
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck.
    Anticancer Res. 2018;38:6485-6490.
    PubMed     Abstract available

  252. ELLIOTT DA, Rana SR, Nabavizadeh N, Chen Y, et al
    Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns.
    Anticancer Res. 2018;38:6375-6379.
    PubMed     Abstract available

  253. ARIMOTO S, Hasegawa T, Takeda D, Saito I, et al
    Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6157-6162.
    PubMed     Abstract available

  254. LEE MK, Park JH, Gi SH, Hwang YS, et al
    IL-1beta Induces Fascin Expression and Increases Cancer Invasion.
    Anticancer Res. 2018;38:6127-6132.
    PubMed     Abstract available

  255. OPITZ P, Herbarth O, Seidel A, Boehm A, et al
    Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
    Anticancer Res. 2018;38:6113-6119.
    PubMed     Abstract available

  256. TURBAT-HERRERA EA, Kilpatrick MJ, Chen J, Meram AT, et al
    Cystathione beta-Synthase Is Increased in Thyroid Malignancies.
    Anticancer Res. 2018;38:6085-6090.
    PubMed     Abstract available

    October 2018
  257. TSIAMBAS E, Riziotis C, Mastronikolis NS, Peschos D, et al
    Comparative p16(IKN4A) Expression in Laryngeal Carcinoma and Cervical Cancer Precursors: A Real-time Grid-based Immunocytochemistry Analysis.
    Anticancer Res. 2018;38:5805-5810.
    PubMed     Abstract available

  258. WOESTEMEIER A, Ghadban T, Riethdorf S, Harms-Effenberger K, et al
    Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
    Anticancer Res. 2018;38:5665-5669.
    PubMed     Abstract available

  259. PARK R, Williamson S, Kasi A, Saeed A, et al
    Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Anticancer Res. 2018;38:5569-5580.
    PubMed     Abstract available

  260. YIN F, Piao J, Liu X, Lai J, et al
    Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls.
    Anticancer Res. 2018;38:5999-6002.
    PubMed     Abstract available

  261. ATHAUDA A, Watkins D, Mohammed K, Chau I, et al
    Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.
    Anticancer Res. 2018;38:5943-5949.
    PubMed     Abstract available

  262. VARRA V, Woody NM, Reddy C, Joshi NP, et al
    Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
    Anticancer Res. 2018;38:5825-5830.
    PubMed     Abstract available

  263. KANG SM, Kim J, Kang SH, Oh SY, et al
    Up-regulation of Bone Morphogenetic Protein 7 by 2-Hydroxycinnamaldehyde Attenuates HNSCC Cell Invasion.
    Anticancer Res. 2018;38:5747-5757.
    PubMed     Abstract available

  264. KIM JY, Park Y, Lee BM, Kim HS, et al
    P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Anticancer Res. 2018;38:5685-5692.
    PubMed     Abstract available

  265. VIRGILIO E, Ceci D, Cavallini M
    Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:5581-5587.
    PubMed     Abstract available

    September 2018
  266. BETTE M, Nowak-Rossmann A, Mandic R
    The Auricular VX2 Carcinoma Is a Suitable Animal Model for Identifying Biomarkers for HNSCC Therapy Response.
    Anticancer Res. 2018;38:5067-5078.
    PubMed     Abstract available

  267. ARIGAMI T, Uchikado Y, Omoto I, Sasaki K, et al
    Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5447-5452.
    PubMed     Abstract available

  268. MERZ S, Timmesfeld N, Stuck BA, Wiegand S, et al
    Impact of Lymph Node Yield on Outcome of Patients with Head and Neck Cancer and pN0 Neck.
    Anticancer Res. 2018;38:5347-5350.
    PubMed     Abstract available

  269. HAYATA K, Ojima T, Nakamori M, Nakamura M, et al
    Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
    Anticancer Res. 2018;38:5267-5273.
    PubMed     Abstract available

  270. HEJLEH TA, Abushahin L, Keech J, Allen BG, et al
    Screening Patients with Esophageal Cancer to Determine Eligibility for Adjuvant Treatment Trials.
    Anticancer Res. 2018;38:5247-5251.
    PubMed     Abstract available

  271. JIANG P, Gu L, Zhou Y, Zhao Y, et al
    Synchronous Laryngeal Squamous Cell Carcinoma and Intrahepatic Cholangiocarcinoma Present in an Obese Male with Poor Prognosis.
    Anticancer Res. 2018;38:5547-5550.
    PubMed     Abstract available

  272. KUWAHARA T, Takahashi H, Sano D, Matsuoka M, et al
    Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5321-5330.
    PubMed     Abstract available

  273. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Abstract available

  274. FURUKAWA T, Hamai Y, Hihara J, Emi M, et al
    Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.
    Anticancer Res. 2018;38:5239-5245.
    PubMed     Abstract available

  275. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:5211-5216.
    PubMed     Abstract available

  276. KIM H, Yang JM, Ahn SH, Jeong WJ, et al
    Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5193-5200.
    PubMed     Abstract available

  277. KIM JY, Son JY, Lee BM, Kim HS, et al
    Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Anticancer Res. 2018;38:5149-5157.
    PubMed     Abstract available

    August 2018
  278. KONISHI T, Shiozaki A, Fujiwara H, Konishi H, et al
    Comparison of Feeding Jejunostomy via Gastric Tube Versus Jejunum After Esophageal Cancer Surgery.
    Anticancer Res. 2018;38:4941-4945.
    PubMed     Abstract available

  279. RADES D, Staackmann C, Janssen S
    Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer.
    Anticancer Res. 2018;38:4833-4837.
    PubMed     Abstract available

  280. BERSANI C, Haeggblom L, Ursu RG, Giusca SE, et al
    Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
    Anticancer Res. 2018;38:4683-4690.
    PubMed     Abstract available

  281. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4661-4666.
    PubMed     Abstract available

  282. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 3-(N-Cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:4459-4467.
    PubMed     Abstract available

  283. NAGAI J, Shi H, Kubota Y, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of Pyrano[4,3-b]chromones.
    Anticancer Res. 2018;38:4449-4457.
    PubMed     Abstract available

    July 2018
  284. STROJAN P, Zakotnik B, Zumer B, Karner K, et al
    Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer.
    Anticancer Res. 2018;38:4213-4220.
    PubMed     Abstract available

  285. STAACKMANN C, Janssen S, Schild SE, Rades D, et al
    A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.
    Anticancer Res. 2018;38:4199-4202.
    PubMed     Abstract available

  286. BAXA J, Ferda J, Ferdova E, Vojtisek R, et al
    Hybrid Imaging PET/CT with Application of (18)F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy.
    Anticancer Res. 2018;38:4153-4157.
    PubMed     Abstract available

  287. ALOTAIBY F, Song F, Boyce BJ, Cao D, et al
    Unusual Papillary Squamous Cell Carcinoma of the Tip of Tongue Presenting in a Patient Status Post Heart Transplant.
    Anticancer Res. 2018;38:4203-4206.
    PubMed     Abstract available

  288. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Associations Between MTHFR Polymorphisms and the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4021-4026.
    PubMed     Abstract available

  289. MOREIRA LF, Maino MM, Garbin HI, DA Natividade GR, et al
    CD117 Expression in Squamous Cell Carcinoma of the Oesophagus.
    Anticancer Res. 2018;38:3929-3933.
    PubMed     Abstract available

  290. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-(N-cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:3897-3906.
    PubMed     Abstract available

  291. MERAM AT, Chen J, Patel S, Kim DD, et al
    Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.
    Anticancer Res. 2018;38:3843-3852.
    PubMed     Abstract available

    June 2018
  292. SIANO M, Jarisch N, Joerger M, Espeli V, et al
    Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer.
    Anticancer Res. 2018;38:3725-3729.
    PubMed     Abstract available

  293. RADES D, Bartscht T, Idel C, Schild SE, et al
    Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with >/=42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.
    Anticancer Res. 2018;38:3653-3656.
    PubMed     Abstract available

  294. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Abstract available

  295. KIM JS, Choi DW, Kim CS, Yu SK, et al
    MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells.
    Anticancer Res. 2018;38:3477-3485.
    PubMed     Abstract available

  296. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Abstract available

  297. JULOORI A, Koyfman SA, Geiger JL, Joshi NP, et al
    Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
    Anticancer Res. 2018;38:3543-3549.
    PubMed     Abstract available

  298. UESAWA Y, Sakagami H, Shi H, Hirose M, et al
    Quantitative Structure-Cytotoxicity Relationship of Furo[2,3-b]chromones.
    Anticancer Res. 2018;38:3283-3290.
    PubMed     Abstract available

  299. BOLM L, Kasmann L, Paysen A, Karapetis C, et al
    Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:3231-3242.
    PubMed     Abstract available

  300. GANESH D, Sreenivasan P, Ohman J, Wallstrom M, et al
    Potentially Malignant Oral Disorders and Cancer Transformation.
    Anticancer Res. 2018;38:3223-3229.
    PubMed     Abstract available

    May 2018
  301. CHOI SH, Chang JS, Choi J, Park SH, et al
    Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Anticancer Res. 2018;38:3165-3173.
    PubMed     Abstract available

  302. RAMQVIST T, Ursu RG, Haeggblom L, Mirzaie L, et al
    Human Polyomaviruses Are Not Frequently Present in Cancer of the Salivary Glands.
    Anticancer Res. 2018;38:2871-2874.
    PubMed     Abstract available

  303. ASSAO A, Yoshino PM, Medeiros MCM, Carvalho AL, et al
    Moesin Involvement in Oral Carcinogenesis of the Lower Lip.
    Anticancer Res. 2018;38:2755-2760.
    PubMed     Abstract available

  304. KRAMER B, Kneissle M, Birk R, Rotter N, et al
    Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.
    Anticancer Res. 2018;38:2723-2731.
    PubMed     Abstract available

    April 2018
  305. FARINA E, Capuccini J, Macchia G, Caravatta L, et al
    Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.
    Anticancer Res. 2018;38:2409-2414.
    PubMed     Abstract available

  306. SHIMAKAWA T, Naritaka Y, Asaka S, Miyazawa M, et al
    Innovations for Cervical Esophagogastrostomy in Thoracic Esophageal Cancer Operations.
    Anticancer Res. 2018;38:2323-2327.
    PubMed     Abstract available

  307. SHIH LC, Li CH, Sun KT, Chen LY, et al
    Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
    Anticancer Res. 2018;38:2087-2092.
    PubMed     Abstract available

  308. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Abstract available

  309. MASTRONIKOLIS NS, Tsiambas E, Fotiades PP, Baliou E, et al
    Numerical Imbalances of Chromosome 7 in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:2339-2342.
    PubMed     Abstract available

  310. FRIEDRICH RE, Reul A
    Periapical Cemento-osseous Dysplasia Is Rarely Diagnosed on Orthopantomograms of Patients with Neurofibromatosis Type 1 and Is Not a Gender-specific Feature of the Disease.
    Anticancer Res. 2018;38:2277-2284.
    PubMed     Abstract available

  311. SEDER CW, Mahon B, Hennon M, Thomas M, et al
    Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma.
    Anticancer Res. 2018;38:2195-2200.
    PubMed     Abstract available

    March 2018
  312. BERNARDI D, Asti E, Aiolfi A, Bonitta G, et al
    Outcome of Trimodal Therapy in Elderly Patients with Esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index.
    Anticancer Res. 2018;38:1815-1820.
    PubMed     Abstract available

  313. KUNIZAKI M, Hamasaki K, Wakata K, Tobinaga S, et al
    Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1807-1813.
    PubMed     Abstract available

  314. SUROV A, Leifels L, Meyer HJ, Winter K, et al
    Associations Between Histogram Analysis DCE MRI Parameters and Complex (18)F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1637-1642.
    PubMed     Abstract available

  315. RADES D, Seidl D, Janssen S, Hakim SG, et al
    A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers.
    Anticancer Res. 2018;38:1611-1613.
    PubMed     Abstract available

  316. GUO JC, Lin CC, Huang TC, Huang PM, et al
    Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:1569-1577.
    PubMed     Abstract available

  317. LEE CC, Lin ML, Meng M, Chen SS, et al
    Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
    Anticancer Res. 2018;38:1377-1389.
    PubMed     Abstract available

  318. GLAAS MF, Wiek C, Wolter LM, Roellecke K, et al
    Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2018;38:1317-1325.
    PubMed     Abstract available

  319. ZIVICOVA V, Gal P, Mifkova A, Novak S, et al
    Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1279-1290.
    PubMed     Abstract available

  320. SUEFUJI H, Koto M, Demizu Y, Saitoh JI, et al
    A Retrospective Multicenter Study of Carbon Ion Radiotherapy for Locally Advanced Olfactory Neuroblastomas.
    Anticancer Res. 2018;38:1665-1670.
    PubMed     Abstract available

  321. POST CM, Lin C, Adeberg S, Gupta M, et al
    National Practice Patterns for Clinical T1N0 Nasopharyngeal Cancer in the Elderly: A National Cancer Data Base Analysis.
    Anticancer Res. 2018;38:1651-1657.
    PubMed     Abstract available

  322. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Abstract available

  323. KAWASAKI G, Naruse T, Furukawa K, Umeda M, et al
    mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study.
    Anticancer Res. 2018;38:1623-1628.
    PubMed     Abstract available

  324. YUDA M, Nishikawa K, Takahashi K, Kurogochi T, et al
    A Strategy for Using Intraoperative Nerve Monitoring During Esophagectomy to Prevent Recurrent Laryngeal Nerve Palsy.
    Anticancer Res. 2018;38:1563-1567.
    PubMed     Abstract available

  325. SU W, Miles BA, Posner M, Som P, et al
    Surveillance Imaging in HPV-related Oropharyngeal Cancer.
    Anticancer Res. 2018;38:1525-1529.
    PubMed     Abstract available

  326. KATO K, Shimasaki M, Kato T, Segami N, et al
    Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1361-1368.
    PubMed     Abstract available

  327. SAIDAK Z, Morisse MC, Chatelain D, Sauzay C, et al
    Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours.
    Anticancer Res. 2018;38:1343-1352.
    PubMed     Abstract available

  328. HATA M
    Radiation Therapy for Angiosarcoma of the Scalp: Total Scalp Irradiation and Local Irradiation.
    Anticancer Res. 2018;38:1247-1253.
    PubMed     Abstract available

    February 2018
  329. KONISHI H, Fujiwara H, Shiozaki A, Shoda K, et al
    Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1017-1023.
    PubMed     Abstract available

  330. SAKAI M, Sohda M, Miyazaki T, Yoshida T, et al
    Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy.
    Anticancer Res. 2018;38:933-938.
    PubMed     Abstract available

  331. NAKAJIMA M, Muroi H, Kikuchi M, Takahashi M, et al
    Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
    Anticancer Res. 2018;38:911-918.
    PubMed     Abstract available

  332. YANAGI M, Sasaki K, Uchikado Y, Omoto I, et al
    Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer.
    Anticancer Res. 2018;38:893-900.
    PubMed     Abstract available

  333. ERNST BP, Mikstas C, Stover T, Stauber R, et al
    Association of eIF4E and SPARC Expression with Lymphangiogenesis and Lymph Node Metastasis in Hypopharyngeal Cancer.
    Anticancer Res. 2018;38:699-706.
    PubMed     Abstract available

  334. TATEBE H, Doi H, Ishikawa K, Kawakami H, et al
    Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Anticancer Res. 2018;38:979-986.
    PubMed     Abstract available

  335. YOSHIDA S, Shimo T, Murase Y, Takabatake K, et al
    The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:955-962.
    PubMed     Abstract available

  336. SAKAGAMI H, Okudaira N, Uesawa Y, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Azolylchromones.
    Anticancer Res. 2018;38:763-770.
    PubMed     Abstract available

  337. UESAWA Y, Sakagami H, Okudaira N, Toda K, et al
    Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
    Anticancer Res. 2018;38:817-823.
    PubMed     Abstract available

  338. CIERPIKOWSKI P, Lis-Nawara A, Gajdzis P, Bar J, et al
    PDGFRalpha/HER2 and PDGFRalpha/p53 Co-expression in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:795-802.
    PubMed     Abstract available

    January 2018
  339. EGUCHI K, Suzuki M, Ida S, Mori K, et al
    Association Between Laryngopharyngeal Reflux and Radiation-induced Mucositis in Head and Neck Cancer.
    Anticancer Res. 2018;38:477-480.
    PubMed     Abstract available

  340. RADES D, Bartscht T, Idel C, Hakim SG, et al
    Re-irradiation with 36 Gy (1.5 Gy Twice Daily) Plus Paclitaxel for Advanced Recurrent and Previously Irradiated SCCHN is Feasible.
    Anticancer Res. 2018;38:519-523.
    PubMed     Abstract available

  341. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Abstract available

  342. DOMINGUEZ C, Rosa M, George TB, Pimiento J, et al
    Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
    Anticancer Res. 2018;38:367-372.
    PubMed     Abstract available

  343. ISHIBASHI K, Ishii K, Sugiyama G, Sumida T, et al
    Deregulation of Nicotinamide N-Methyltransferase and Gap Junction Protein Alpha-1 Causes Metastasis in Adenoid Cystic Carcinoma.
    Anticancer Res. 2018;38:187-197.
    PubMed     Abstract available

    December 2017
  344. ANDREOU A, Pesthy S, Struecker B, Dadras M, et al
    Incidence and Risk Factors of Symptomatic Hiatal Hernia Following Resection for Gastric and Esophageal Cancer.
    Anticancer Res. 2017;37:7031-7036.
    PubMed     Abstract available

  345. SENTO S, Kitamura N, Yamamoto T, Nakashiro K, et al
    Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients.
    Anticancer Res. 2017;37:6977-6981.
    PubMed     Abstract available

  346. FARINA E, Ferioli M, Castellucci P, Farina A, et al
    (18)F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art.
    Anticancer Res. 2017;37:6523-6532.
    PubMed     Abstract available

  347. RADES D, Bajrovic A, Bartscht T
    Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands.
    Anticancer Res. 2017;37:7011-7015.
    PubMed     Abstract available

  348. KOTSUMA T, Yamazaki H, Masui K, Yoshida K, et al
    Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Anticancer Res. 2017;37:6887-6892.
    PubMed     Abstract available

  349. FUJII H, Iihara H, Kajikawa N, Kobayashi R, et al
    Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.
    Anticancer Res. 2017;37:6831-6837.
    PubMed     Abstract available

  350. KURODA H, Kurio N, Shimo T, Matsumoto K, et al
    Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.
    Anticancer Res. 2017;37:6731-6737.
    PubMed     Abstract available

    November 2017
  351. CHO JH, Joo YH, Shin EY, Park EJ, et al
    Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:6269-6280.
    PubMed     Abstract available

  352. LIU KC, Lin YJ, Hsiao YT, Lin ML, et al
    Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.
    Anticancer Res. 2017;37:6107-6118.
    PubMed     Abstract available

  353. CHOU PY, Lee MM, Lin SY, Sheu MJ, et al
    Pipoxolan Exhibits Antitumor Activity Toward Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-mediated Apoptosis.
    Anticancer Res. 2017;37:6391-6400.
    PubMed     Abstract available

  354. UESAWA Y, Sakagami H, Ikezoe N, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of Aurones.
    Anticancer Res. 2017;37:6169-6176.
    PubMed     Abstract available

  355. SAKAGAMI H, Uesawa Y, Masuda Y, Tomomura M, et al
    Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
    Anticancer Res. 2017;37:6161-6168.
    PubMed     Abstract available

  356. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:6119-6123.
    PubMed     Abstract available

  357. SUGITA Y, Takao K, Uesawa Y, Sakagami H, et al
    Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity.
    Anticancer Res. 2017;37:5919-5924.
    PubMed     Abstract available

    October 2017
  358. MOTOYAMA S, Sato Y, Sasaki T, Wakita A, et al
    Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Anticancer Res. 2017;37:5837-5843.
    PubMed     Abstract available

  359. HAMAI Y, Hihara J, Emi M, Furukawa T, et al
    Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5639-5646.
    PubMed     Abstract available

  360. GOPPEL J, Mockelmann N, Munscher A, Sauter G, et al
    Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:5435-5440.
    PubMed     Abstract available

  361. LIM HS, Kim CS, Kim JS, Yu SK, et al
    Suppression of Oral Carcinoma Oncogenic Activity by microRNA-203 via Down-regulation of SEMA6A.
    Anticancer Res. 2017;37:5425-5433.
    PubMed     Abstract available

  362. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Abstract available

  363. JANG JY, Pak KJ, Yi KI, Ki YK, et al
    Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
    Anticancer Res. 2017;37:5899-5905.
    PubMed     Abstract available

  364. FUJIMOTO Y, Nakashima Y, Sasaki S, Jogo T, et al
    Chemoradiotherapy for Solitary Skeletal Muscle Metastasis from Oesophageal Cancer: Case Report and Brief Literature Review.
    Anticancer Res. 2017;37:5687-5691.
    PubMed     Abstract available

  365. MASTRONIKOLIS NS, Tsiambas E, Papadas TA, Karameris A, et al
    Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.
    Anticancer Res. 2017;37:5521-5524.
    PubMed     Abstract available

  366. PISANI LP, Estadella D, Ribeiro DA
    The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
    Anticancer Res. 2017;37:5389-5394.
    PubMed     Abstract available

  367. ANGELIERI F, Yujra VQ, Oshima CTF, Ribeiro DA, et al
    Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review.
    Anticancer Res. 2017;37:5383-5388.
    PubMed     Abstract available

  368. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Abstract available

    September 2017
  369. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer.
    Anticancer Res. 2017;37:5301-5307.
    PubMed     Abstract available

  370. SOHDA M, Kumakura Y, Saito H, Kuriyama K, et al
    Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival.
    Anticancer Res. 2017;37:5045-5051.
    PubMed     Abstract available

  371. KUMABE A, Zenda S, Motegi A, Onozawa M, et al
    Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5039-5044.
    PubMed     Abstract available

  372. FRANZEN AM, Coordes A, Franzen CK, Guenzel T, et al
    Are Multiple Tumors of the Parotid Gland Uncommon or Underestimated?
    Anticancer Res. 2017;37:5263-5267.
    PubMed     Abstract available

  373. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Abstract available

  374. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Abstract available

  375. GUTSCHENRITTER T, Machiorlatti M, Vesely S, Ahmad B, et al
    Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.
    Anticancer Res. 2017;37:5019-5025.
    PubMed     Abstract available

  376. OKAMOTO JY, Miyazaki A, Kobayashi JI, Miyamoto S, et al
    Induction and Analysis of Cytotoxic T-Lymphocytes that Recognize Autologous Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4889-4897.
    PubMed     Abstract available

    August 2017
  377. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Abstract available

  378. LV Y, Jia C, Jiang A, Zhang H, et al
    Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer.
    Anticancer Res. 2017;37:4399-4403.
    PubMed     Abstract available

  379. MOTOYAMA S, Sato Y, Maruyama K, Usami S, et al
    Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer.
    Anticancer Res. 2017;37:4189-4194.
    PubMed     Abstract available

  380. HONJO H, Toh Y, Sohda M, Suzuki S, et al
    Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4147-4155.
    PubMed     Abstract available

  381. PARK Y, Son JY, Lee BM, Kim HS, et al
    Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Anticancer Res. 2017;37:4139-4146.
    PubMed     Abstract available

  382. KLATKA J, Grywalska E, Hymos A, Guz M, et al
    Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer.
    Anticancer Res. 2017;37:4059-4066.
    PubMed     Abstract available

  383. WANG Y, Xu G, Wang J, Li XH, et al
    Relationship of Th17/Treg Cells and Radiation Pneumonia in Locally Advanced Esophageal Carcinoma.
    Anticancer Res. 2017;37:4643-4647.
    PubMed     Abstract available

  384. ZHANG W, Yin G, Dai J, Sun YU, et al
    Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-kappaB Signaling Pathway in DMBA-treated Hamsters.
    Anticancer Res. 2017;37:4041-4049.
    PubMed     Abstract available

  385. REITER M, Harreus U
    Total Glossectomy Without Laryngectomy for Advanced Squamous Cell Cancer of the Tongue: Functional and Oncological Results.
    Anticancer Res. 2017;37:4233-4237.
    PubMed     Abstract available

    July 2017
  386. KITAGAWA H, Namikawa T, Hanazaki K
    Neck Dissection and Thoracoscopic Esophagectomy in Esophageal Cancer with Aberrant Subclavian Artery.
    Anticancer Res. 2017;37:3787-3790.
    PubMed     Abstract available

  387. HONMA Y, Hokamura N, Nagashima K, Sudo K, et al
    Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Anticancer Res. 2017;37:3741-3749.
    PubMed     Abstract available

  388. USLU U, Schuler G, Breuninger H
    Factors Influencing Disease Progression in Patients with Head and Neck Melanoma.
    Anticancer Res. 2017;37:3811-3816.
    PubMed     Abstract available

  389. FENG X, Matsuo K, Zhang T, Hu Y, et al
    MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2017;37:3473-3481.
    PubMed     Abstract available

    June 2017
  390. KAWAI T, Kochi M, Fujii M, Song K, et al
    Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:3301-3306.
    PubMed     Abstract available

  391. KALFERT D, Ludvikova M, Topolcan O, Celakovsky P, et al
    Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:3281-3286.
    PubMed     Abstract available

  392. UCHIYAMA Y, Kreiborg S, Murakami S, Tsujimoto T, et al
    Changes in the Submandibular Gland in Patients with Head and Neck Cancer After Radiation Therapy: A Preliminary Study.
    Anticancer Res. 2017;37:3239-3242.
    PubMed     Abstract available

  393. TARVAINEN L, Suojanen J, Kyyronen P, Lindqvist C, et al
    Occupational Risk for Oral Cancer in Nordic Countries.
    Anticancer Res. 2017;37:3221-3228.
    PubMed     Abstract available

  394. SUZUKI G, Yamazaki H, Aibe N, Masui K, et al
    Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: Factors Affecting Swallowing and Survival.
    Anticancer Res. 2017;37:3085-3092.
    PubMed     Abstract available

  395. MIYATA H, Sugimura K, Motoori M, Fujiwara Y, et al
    Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2017;37:3053-3059.
    PubMed     Abstract available

  396. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Abstract available

  397. JANG S, Patel PN, Kimple RJ, McCulloch TM, et al
    Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
    Anticancer Res. 2017;37:3045-3052.
    PubMed     Abstract available

  398. KRAMER B, Hock C, Schultz JD, Lammert A, et al
    Impact of Small Molecules on beta-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:2845-2852.
    PubMed     Abstract available

    May 2017
  399. RADES D, Maderer A, Panzner A, Hunold P, et al
    Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
    Anticancer Res. 2017;37:2703-2708.
    PubMed     Abstract available

  400. ZIVICOVA V, Broz P, Fik Z, Mifkova A, et al
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin.
    Anticancer Res. 2017;37:2275-2288.
    PubMed     Abstract available

  401. HAGEMANN J, Jacobi C, Hahn M, Schmid V, et al
    Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Anticancer Res. 2017;37:2201-2210.
    PubMed     Abstract available

  402. CIESIELSKA U, Zatonski T, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Anticancer Res. 2017;37:2407-2415.
    PubMed     Abstract available

    April 2017
  403. VEGH D, Banyai D, Hermann P, Nemeth Z, et al
    Type-2 Diabetes Mellitus and Oral Tumors in Hungary: A Long-term Comparative Epidemiological Study.
    Anticancer Res. 2017;37:1853-1857.
    PubMed     Abstract available

  404. DAVE E, Su W, Gupta V, Miles B, et al
    Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Anticancer Res. 2017;37:1847-1851.
    PubMed     Abstract available

  405. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Abstract available

  406. P NS, Kang DY, Kim BJ, Joung YH, et al
    Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells.
    Anticancer Res. 2017;37:1637-1646.
    PubMed     Abstract available

  407. SHIMIZU H, Shiozaki A, Fujiwara H, Konishi H, et al
    Short- and Long-term Progress of Recurrent Laryngeal Nerve Paralysis After Subtotal Esophagectomy.
    Anticancer Res. 2017;37:2019-2023.
    PubMed     Abstract available

  408. YUNOKI T, Tabuchi Y, Hayashi A
    Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Anticancer Res. 2017;37:1931-1934.
    PubMed     Abstract available

  409. FANG CY, Liew PL, Chen CL, Lin YH, et al
    High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1891-1899.
    PubMed     Abstract available

  410. FUJIMURA T, Takahashi K, Kambayashi Y, Furudate S, et al
    Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
    Anticancer Res. 2017;37:1885-1889.
    PubMed     Abstract available

    March 2017
  411. WAKITA A, Motoyama S, Nanjo H, Sato Y, et al
    PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:1433-1441.
    PubMed     Abstract available

  412. TORII C, Hida Y, Shindoh M, Akiyama K, et al
    Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1219-1225.
    PubMed     Abstract available

  413. NAKASHIMA S, Shiozaki A, Ichikawa D, Hikami S, et al
    Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1161-1167.
    PubMed     Abstract available

  414. TSENG HH, Tseng YK, You JJ, Kang BH, et al
    Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Anticancer Res. 2017;37:1059-1066.
    PubMed     Abstract available

  415. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Abstract available

  416. KOGASHIWA Y, Yasuda M, Sakurai H, Nakahira M, et al
    PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1417-1424.
    PubMed     Abstract available

  417. THEOCHARIS S, Kotta-Loizou I, Giaginis C, Alexandrou P, et al
    Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1313-1319.
    PubMed     Abstract available

  418. SAKAGAMI H, Masuda Y, Tomomura M, Yokose S, et al
    Quantitative Structure-Cytotoxicity Relationship of Chalcones.
    Anticancer Res. 2017;37:1091-1098.
    PubMed     Abstract available

  419. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Abstract available

  420. HARA K, Miyazaki T, Yokobori T, Yoshida T, et al
    Significance and Function of MicroRNA-7 in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1043-1048.
    PubMed     Abstract available

  421. SAKAGAMI H, Okudaira N, Masuda Y, Amano O, et al
    Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
    Anticancer Res. 2017;37:1023-1029.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.